<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01142960</url>
  </required_header>
  <id_info>
    <org_study_id>5-ZH73</org_study_id>
    <nct_id>NCT01142960</nct_id>
  </id_info>
  <brief_title>Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population</brief_title>
  <official_title>Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Hong Kong Jockey Club Charities Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the rapid growing aging population, age-related eye diseases including cataract are
      becoming more prevalent. The demand for cataract surgery and post-surgical care posed
      enormous financial burdens to the government.

      Lycium barbarum contains lutein and zeaxanthin which can filter the phototoxic blue light and
      neutralize the reactive oxygen species, thus provide a protective effect against cataract
      formation.

      This study aims to determine the effects of Lycium barbarum Supplements on the progression of
      senile cataract in Hong Kong Chinese elderly.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Please note that a manuscript for this study is being prepared. Detailed description will be
      provided after we come up with the final draft.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lens Opacity Classification System III (LOCSIII)</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">238</enrollment>
  <condition>Lens Opacity</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lycium Barbarum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lycium Barbarum supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Starch</intervention_name>
    <description>1350mg/day</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lycium Barbarum</intervention_name>
    <description>1350mg/day</description>
    <arm_group_label>Lycium Barbarum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unlikely to have cataract surgery within 3 years

          -  Presence of mild to moderate cataract in one or both eyes, graded by Lens Opacities
             Classification System III (LOCSIII).

          -  logMAR acuity equivalent to Snellen acuity of 20/63 or better

          -  no previous history and clinical signs of glaucoma by determining intraocular pressure
             using applanation Tonometry (no more than 22mmHg)

          -  no ocular anomalies: amblyopia, binocular anomalies, ocular trauma

          -  no history of eye surgery, laser treatment, iritis, retinal crystalline deposits,
             macular degeneration, or optic nerve diseases

          -  no extended use of systemic or ocular corticosteroid drugs

          -  no concurrent participation of other systemic or ocular drug intervention study

        Exclusion Criteria:

          -  diabetes mellitus

          -  renal failure

          -  fat malabsorption syndrome

          -  intestinal surgery history

          -  chronic diarrhea

          -  alcoholism

          -  use of anticoagulants

          -  regular use of nutritional supplements such as multi-vitamin, mineral and other
             antioxidant supplements (including Omega-3)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chi-wai Do, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chea-su Kee, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hong Kong Polytechnic University</name>
      <address>
        <city>Hung Hom</city>
        <state>Kowloon</state>
        <zip>0000</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2010</study_first_submitted>
  <study_first_submitted_qc>June 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2010</study_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
    <investigator_full_name>Chea-su Kee</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

